519 672 2121
Close mobile menu

Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.

News & Views

Blog

The more you understand, the easier it is to manage well.

View Blog
26 May 2023 By

Institutional abuse litigation

Throughout Canada, recent years have seen repeated discoveries of abuse in institutional set…

Canadians can now claim under $20 million OxyContin class actions settlement

On May 27, 2023, a claims filing process becomes open to Canadians to apply for compensation…